SCHEMBL5224206

SCHEMBL5224206

COc1cc2c(Oc3ccc(N4C(=O)NC(C)(Cc5ccccc5)C4=O)cc3F)ccnc2cc1OCCCN1CCOCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 3/20 0.61
MET P08581 17/20 0.61
KDR P35968 3/20 0.61
EGFR P00533 3/20 0.61
AURKA O14965 2/20 0.61
LCK P06239 2/20 0.61
CSF1R P07333 2/20 0.61
RPS6KB1 P23443 2/20 0.61
FLT4 P35916 2/20 0.61
TEK Q02763 2/20 0.61
MST1R Q04912 2/20 0.61
BTK Q06187 2/20 0.61
INSR P06213 2/20 0.56
FLT3 P36888 3/20 0.56
SRC P12931 2/20 0.55
PLK4 O00444 1/20 0.55
STK25 O00506 1/20 0.55
CIT O14578 1/20 0.55
CHUK O15111 1/20 0.55
MUSK O15146 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866089 0.84 MET (0.63) AXLMETKDREGFRAURKA
SCHEMBL2863116 0.83 AXL (0.63) AXLMETKDREGFRAURKA
SCHEMBL2861187 0.83 AXL (0.65) AXLMETKDREGFRAURKA
SCHEMBL2856001 0.83 AXL (0.65) AXLMETKDREGFRAURKA
SCHEMBL5223356 0.83 MET (0.61) AXLMETKDREGFRAURKA
SCHEMBL2861493 0.82 AXL (0.62) AXLMETKDREGFRAURKA
SCHEMBL2864821 0.82 AXL (0.62) AXLMETKDREGFRAURKA
SCHEMBL3921526 0.81 MET (0.69) AXLMETKDREGFRAURKA
SCHEMBL2862774 0.81 AXL (0.68) AXLMETKDREGFRAURKA
SCHEMBL13511883 0.81 AXL (0.68) AXLMETKDREGFRAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827434-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER Amgen Inc. (US) 2007-09-05 EP disclosed
WO-2006060318-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER AMGEN INC. (US) 2006-06-08 WO disclosed